CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 11.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,711,277 | +12.0% | 265,032 | +15.5% | 1.12% | +61.7% |
Q4 2022 | $2,420,339 | -15.9% | 229,416 | +2.2% | 0.69% | -29.0% |
Q3 2022 | $2,879,000 | +5.4% | 224,555 | +5.4% | 0.97% | +15.8% |
Q2 2022 | $2,732,000 | +40.1% | 213,090 | +181.4% | 0.84% | -3.3% |
Q2 2021 | $1,950,000 | – | 75,732 | – | 0.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |